DE2530246C2 - - Google Patents
Info
- Publication number
- DE2530246C2 DE2530246C2 DE19752530246 DE2530246A DE2530246C2 DE 2530246 C2 DE2530246 C2 DE 2530246C2 DE 19752530246 DE19752530246 DE 19752530246 DE 2530246 A DE2530246 A DE 2530246A DE 2530246 C2 DE2530246 C2 DE 2530246C2
- Authority
- DE
- Germany
- Prior art keywords
- weight
- amino acid
- acid mixture
- mixture according
- methionine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000008575 L-amino acids Chemical class 0.000 claims 5
- 239000000203 mixture Substances 0.000 claims 4
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims 2
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 claims 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims 2
- 229930195722 L-methionine Natural products 0.000 claims 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims 2
- 229960004452 methionine Drugs 0.000 claims 2
- QDGAVODICPCDMU-UHFFFAOYSA-N 2-amino-3-[3-[bis(2-chloroethyl)amino]phenyl]propanoic acid Chemical compound OC(=O)C(N)CC1=CC=CC(N(CCCl)CCCl)=C1 QDGAVODICPCDMU-UHFFFAOYSA-N 0.000 claims 1
- 208000009304 Acute Kidney Injury Diseases 0.000 claims 1
- 235000013878 L-cysteine Nutrition 0.000 claims 1
- 239000004201 L-cysteine Substances 0.000 claims 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 claims 1
- 235000019393 L-cystine Nutrition 0.000 claims 1
- 239000004158 L-cystine Substances 0.000 claims 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims 1
- 229930182844 L-isoleucine Natural products 0.000 claims 1
- 235000019454 L-leucine Nutrition 0.000 claims 1
- 239000004395 L-leucine Substances 0.000 claims 1
- 208000033626 Renal failure acute Diseases 0.000 claims 1
- 239000004473 Threonine Substances 0.000 claims 1
- 230000001154 acute effect Effects 0.000 claims 1
- 201000011040 acute kidney failure Diseases 0.000 claims 1
- 208000012998 acute renal failure Diseases 0.000 claims 1
- 208000020832 chronic kidney disease Diseases 0.000 claims 1
- 208000022831 chronic renal failure syndrome Diseases 0.000 claims 1
- 229960003067 cystine Drugs 0.000 claims 1
- 229960002885 histidine Drugs 0.000 claims 1
- 229960000310 isoleucine Drugs 0.000 claims 1
- 229960003136 leucine Drugs 0.000 claims 1
- WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical compound CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 claims 1
- 229960002898 threonine Drugs 0.000 claims 1
- 229960004799 tryptophan Drugs 0.000 claims 1
- 229960004441 tyrosine Drugs 0.000 claims 1
- 229960004295 valine Drugs 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19752530246 DE2530246A1 (de) | 1975-07-07 | 1975-07-07 | L-aminosaeuregemische fuer parenterale oder orale anwendung |
| FR7620325A FR2316933A1 (fr) | 1975-07-07 | 1976-07-02 | Melanges de l-aminoacides et leur utilisation therapeutique pour le traitement d'insuffisances hepatiques et renales. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19752530246 DE2530246A1 (de) | 1975-07-07 | 1975-07-07 | L-aminosaeuregemische fuer parenterale oder orale anwendung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE2530246A1 DE2530246A1 (de) | 1977-01-13 |
| DE2530246C2 true DE2530246C2 (enExample) | 1989-08-03 |
Family
ID=5950870
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19752530246 Granted DE2530246A1 (de) | 1975-07-07 | 1975-07-07 | L-aminosaeuregemische fuer parenterale oder orale anwendung |
Country Status (2)
| Country | Link |
|---|---|
| DE (1) | DE2530246A1 (enExample) |
| FR (1) | FR2316933A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2531204C2 (de) * | 1975-07-12 | 1987-01-22 | Fresenius AG, 6380 Bad Homburg | L-Aminosäuregemische für die parenterale oder orale Ernährung |
| JPS5535049A (en) * | 1978-09-04 | 1980-03-11 | Otsuka Pharmaceut Factory Inc | Amino acid transfusion for cancerous patient |
| JPS5536457A (en) * | 1978-09-08 | 1980-03-14 | Ajinomoto Co Inc | Amino acid infusion |
| JPS58126767A (ja) * | 1982-01-22 | 1983-07-28 | Ajinomoto Co Inc | 肝臓病患者用栄養組成物 |
| JPS5916817A (ja) * | 1982-07-16 | 1984-01-28 | Eisai Co Ltd | アミノ酸輸液 |
| US5646187A (en) * | 1992-05-20 | 1997-07-08 | Ab Erik Vinnars | Use of alpha-ketoglutarate |
| IT1289754B1 (it) * | 1996-12-16 | 1998-10-16 | Professional Dietetics Srl | Composizioni a base di aminoacidi |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1667887C2 (de) * | 1968-02-09 | 1978-09-28 | Knauff, Hans Georg, Prof. Dr., 3551 Dagobertshausen | Aminosäurelösung zur parenteralen Infusion |
| AT297935B (de) * | 1968-05-09 | 1972-04-10 | Astra Ab | Verfahren zur Herstellung einer Infusionslösung von essentiellen Aminosäuren zur intravenösen Zufuhr bei urämischen Zuständen |
| US3832465A (en) * | 1971-12-09 | 1974-08-27 | H Ghadimi | Injectable amino acid composition commensurate to the anabolic need of the body and method of using same |
| GB1356370A (en) * | 1972-03-06 | 1974-06-12 | Howard A N | Methods and formulations for the treatment of obesity |
| DE2335215B2 (de) * | 1972-07-13 | 1979-04-05 | The Johns Hopkins University, Baltimore, Md. (V.St.A.) | Verwendung einer Mischung bei der Bekämpfung von zur Urämie führenden Nierenerkrankungen |
| FR2215212B1 (enExample) * | 1973-01-18 | 1976-03-05 | Seperic Ch | |
| GB1442154A (en) * | 1973-04-30 | 1976-07-07 | Walser M | Composition for promotion of protein synthesis and suppression of urea formation in the body |
-
1975
- 1975-07-07 DE DE19752530246 patent/DE2530246A1/de active Granted
-
1976
- 1976-07-02 FR FR7620325A patent/FR2316933A1/fr active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| DE2530246A1 (de) | 1977-01-13 |
| FR2316933B1 (enExample) | 1979-06-29 |
| FR2316933A1 (fr) | 1977-02-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1507951A (en) | Amino acid formulations | |
| DE2530246C2 (enExample) | ||
| ATA925175A (de) | Verfahren zur herstellung von neuen, racemischen oder in der l-form vorliegenden 5-hydroxypropionylamino-2,4,6-trijod-isophthalsaure-bis- (dihydroxypropylamiden) | |
| IE39051L (en) | Peptides | |
| ATE190466T1 (de) | Fungizide zwei- und dreikomponentenmischungen | |
| JPS52139735A (en) | Enrichment of food by methionineedipeptide substituted by amino acid at ccterminal | |
| ATE3860T1 (de) | Verfahren zur herstellung von imidazolidinderivaten. | |
| AT344763B (de) | Pulvermischung zur herstellung von legierungsstahl mit einem niedrigen gehalt an oxidischen einschluessen | |
| ES424240A1 (es) | Procedimiento para realzar el tiempo de fraguado abierto decomposiciones de cemento hidraulicas. | |
| FR2317917A1 (fr) | Melanges de l-aminoacides et leur utilisation therapeutique | |
| ZA753053B (en) | A method of maintaining at very low values the content of cyanide in salt baths containing cyanates | |
| GB1496254A (en) | Nutritive infusion solution and its production | |
| AT349001B (de) | Verfahren zur herstellung von dinitroanthrachinon-gemischen mit einem 1,5- und 1,8-dinitroanthrachinon-gehalt von 70 bis 80 gew.-% | |
| FR2070149A1 (en) | Hypocalcemiant calcitonin m derivatives | |
| GB1398819A (en) | Pharmaceutical compositions containing sulphoglycopeptide salts | |
| JPS5232046A (en) | Polyamide composition | |
| JPS5738709A (en) | Composition for oral purpose | |
| JPS5221054A (en) | Polyamide composition | |
| SU487090A1 (ru) | Поливинилхлоридна композици | |
| ES424647A1 (es) | Procedimiento para la obtencion de nuevas dotriacontapepti-doamidas. | |
| JPS52127927A (en) | Thermosetting coating compositions | |
| SU1096920A1 (ru) | Взрывчатый состав | |
| BE891327Q (fr) | N-(benzyl ortho substitue)-dinitrotrifluoromethyl-anilines et compositions les contenant comme agents de regulation de la croissance de plantes | |
| FR2355857A1 (fr) | Procede d'amelioration de la resistance a vert de melanges d'elastomeres synthetiques et de cis-1,4-polyisoprene naturel ou synthetique et composition pour sa mise en oeuvre | |
| FR2247088A5 (en) | Method of positioning struts around ppakages - uses ccccloth tapes to join top and side struts before posittttioning |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8125 | Change of the main classification |
Ipc: A61K 31/195 |
|
| 8126 | Change of the secondary classification |
Ipc: A61K 31/40 |
|
| 8127 | New person/name/address of the applicant |
Owner name: FRESENIUS AG, 6380 BAD HOMBURG, DE |
|
| D2 | Grant after examination | ||
| 8363 | Opposition against the patent |